Several pathways, such as cadherin, Alzheimer's disease, and angiogenesis signaling, highlighted to be associated with WBP2 in this proteogenomic study have yet been explored. The gene discussed is WBP2; the disease is early-onset autosomal dominant Alzheimer disease.